| Product Code: ETC066723 | Publication Date: Aug 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Bahrain Infectious Disease Point-of-care Testing Market was estimated at USD 280 Million in 2025 and is projected to reach USD 356 Million by 2032, growing at a CAGR of 3.5% from 2026 to 2032. This anticipated growth is driven by an increasing emphasis on rapid diagnostics, which has gained significant traction amid the ongoing concerns surrounding infectious disease outbreaks. Furthermore, Bahrain's investment in healthcare infrastructure, combined with the rising awareness about the importance of early detection and treatment, is fostering a robust environment for the adoption of point-of-care testing (POCT) technologies.
This graph highlights how the Bahrain Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -2.4% | Increasing adoption of advanced technologies |
| 2022 | 7.1% | Increasing industrial infrastructure investments |
| 2023 | 7.3% | Expansion of commercial construction activities |
| 2024 | 1.8% | Increasing adoption of advanced technologies |
| 2025 | 2.3% | Expansion of manufacturing activities |
| 2026 | 3.5% | Expansion of commercial construction activities |
| 2027 | 4.0% | Increasing adoption of advanced technologies |
| 2028 | 5.2% | Government infrastructure modernization initiatives |
| 2029 | 5.5% | Government infrastructure modernization initiatives |
| 2030 | 5.1% | Rising electricity demand across industries |
| 2031 | 5.0% | Increasing industrial automation investments |
| 2032 | 4.9% | Increasing adoption of advanced technologies |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The demand for point-of-care testing solutions in Bahrain is being bolstered by a growing population and the simultaneous rise in chronic and infectious diseases. The COVID-19 pandemic has accentuated the need for portable, efficient testing mechanisms that can be implemented swiftly in various healthcare settings, particularly in remote areas.
Additionally, government initiatives aimed at enhancing public health have spurred investments in diagnostic technologies, leading to increased accessibility of testing devices in hospitals, clinics, and community health settings. This creates a conducive landscape for stakeholders looking to innovate and expand in this market.
Despite the promising growth trajectory of the Bahrain Infectious Disease Point-of-care Testing Market, certain factors present significant restraints. The high cost of advanced diagnostic equipment and testing kits serves as a barrier, particularly for smaller healthcare facilities that may struggle with budgeting for such technologies. Additionally, the market's heavy reliance on imported devices leads to increased prices due to shipping and import duties. This further complicates the availability and accessibility of POCT solutions, particularly in less urbanized areas. Moreover, the necessity for specialized training to effectively use advanced diagnostic devices adds operational complexities for healthcare providers, hindering overall market expansion.
Current trends within the Bahrain Infectious Disease Point-of-care Testing Market indicate a strong push towards integrating digital health technologies, such as telemedicine and mobile health applications. These innovations enhance the efficiency of testing processes and follow-up care. Additionally, increased collaboration between healthcare providers and technology developers is fostering a wave of innovation, particularly in the field of rapid diagnostic kits. Moreover, as public health policy prioritizes infectious disease management, there is a marked shift towards preventive healthcare, which is significantly influencing the demand for POCT devices.
Investment opportunities in the Bahrain Infectious Disease Point-of-care Testing Market are substantial, particularly in developing affordable and effective diagnostic solutions. Key areas include the production of rapid tests for prevalent infectious diseases, such as COVID-19 and influenza. Moreover, as awareness of infectious diseases expands, so does the potential for innovations that cater to niche markets within Bahrain's diverse healthcare system. Collaborations with local healthcare providers and government agencies can also create avenues for enhanced market penetration and deployment of advanced technologies.
The Bahraini government is actively promoting initiatives aimed at improving public health outcomes through enhanced disease management frameworks. These policies support the availability and development of rapid diagnostic tools as a strategic measure to control the spread of infectious diseases. Investment in healthcare infrastructure further emphasizes the necessity for efficient point-of-care testing devices in hospitals and clinics, facilitating timely detection and treatment. Such initiatives underscore a broader commitment to healthcare innovation and responsiveness in the face of emerging health threats.
Looking ahead to the years 2026 through 2032, the Bahrain Infectious Disease Point-of-care Testing Market is set to experience a paradigm shift driven by technological advancements and evolving healthcare needs. The integration of artificial intelligence and machine learning into diagnostic processes is likely to enhance the accuracy and efficiency of testing. Furthermore, as public health policies continue to evolve, the prioritization of infectious disease management will catalyze further investment in rapid diagnostic technologies, positioning the market for sustained growth and innovation.
Recent developments in the Bahrain Infectious Disease Point-of-care Testing Market have been characterized by a surge in partnerships between healthcare providers and technology companies focused on innovation. There has been an increased introduction of cost-effective POCT devices designed to enhance testing capabilities across various healthcare settings. Additionally, ongoing training and education programs are being implemented to equip healthcare professionals with the skills needed to leverage these advanced testing technologies effectively.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahrain Infectious Disease Point-of-care Testing Market Overview |
3.1 Bahrain Country Macro Economic Indicators |
3.2 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Bahrain Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Bahrain Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.6 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2022 & 2032F |
3.7 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Bahrain Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Bahrain |
4.2.2 Growing demand for rapid and accurate diagnostic solutions |
4.2.3 Government initiatives to improve healthcare infrastructure and access to point-of-care testing |
4.3 Market Restraints |
4.3.1 Limited awareness and adoption of point-of-care testing in Bahrain |
4.3.2 High cost associated with point-of-care testing devices and consumables |
4.3.3 Lack of skilled healthcare professionals trained in operating point-of-care testing devices |
5 Bahrain Infectious Disease Point-of-care Testing Market Trends |
6 Bahrain Infectious Disease Point-of-care Testing Market, By Types |
6.1 Bahrain Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2022-2032F |
6.1.3 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2022-2032F |
6.1.4 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2022-2032F |
6.1.5 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2022-2032F |
6.1.6 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2022-2032F |
6.1.7 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
6.2 Bahrain Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2022-2032F |
6.2.3 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2022-2032F |
6.2.4 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2022-2032F |
6.2.5 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2022-2032F |
6.3 Bahrain Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F |
6.3.3 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.4 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2022-2032F |
6.3.5 Bahrain Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Bahrain Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Bahrain Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Bahrain Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Bahrain Infectious Disease Point-of-care Testing Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Number of healthcare facilities offering point-of-care testing services |
8.3 Rate of adoption of point-of-care testing by healthcare providers |
9 Bahrain Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Bahrain Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.2 Bahrain Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2022 & 2032F |
9.3 Bahrain Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Bahrain Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Bahrain Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2025 |
10.2 Bahrain Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here